ZFUZE Spinal Interbody Fusion Cages

About DiFusion Technologies

DiFusion Technologies is pioneering a new paradigm in biomaterials by focusing on immune system modulation rather than just mechanical properties. Its flagship ZFUZE technology is a hydrophilic, negatively-charged composite polymer derived from PEEK and ceramic zeolite, which has demonstrated the ability to shift macrophage response from pro-inflammatory (M1) to pro-healing (M2) phenotypes. With FDA clearance and compelling early clinical data showing high fusion rates, the company is positioned to challenge traditional inert materials like PEEK and titanium in the multi-billion dollar spinal implant market. DiFusion operates as a private, commercial-stage company leveraging a specialized polymer platform.

Therapeutic Areas